A Randomized Phase II Study of Erdafitinib Versus Investigator Choice of Intravesicular Chemotherapy in Subjects Who Received Bacillus Calmette-Gu�rin BCG and Progressed or Recurred With High Risk Non-Muscle-Invasive Bladder Cancer NMIBC and FGFR Mutations or Fusions

Brief Summary

Type:
Bladder

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT04172675

Study #:
STUDY00146075

Start Date:
Sep 21, 2021

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04172675

View Complete Trial Details & Eligibility at ClinicalTrials.gov